Finland· FI-REL-REL23285
Movere
A glucosamine product containing glucosamine hydrochloride, registered in Finland by Antula Healthcare AB. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Glucosamine is registered in 14 of 19 countries.
Countries holding a registration under ATC M01AX05 (glucosamine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Glucosamine · ATC M01AX05
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
Price per daily dose
What a daily dose of glucosamine costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Glucosamine · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- ES Spain$0.23
The record
At a glance
Fimea (Finland)- Active substance
- Glucosamine hydrochloride
- Manufacturer
- Antula Healthcare AB
- Country
- Finland (FI)
- ATC code
- M01AX05
- ATC class
- Glucosamine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for glucosamine.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glucosamine · interactions on record
2 records
- 2 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glucosamine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainGLUFAN 625 mg COMPRIMIDOS RECUBIERTOS CON PELICULALaboratorios Farmaceuticos Rovi S.A.
- SwedenGlufan 625 mg Filmdragerad tablettLaboratorios Farmacéuticos ROVI S.A.
- United KingdomAlateris 625mg tabletsMWK Healthcare Ltd
- PolandArthrylMedezin Sp. z o.o.
- CzechiaARTAXINLaboratorio Reig Jofré S.A., Barcelona
- IrelandArthrimel 1500mg Film Coated TabletsPhoenix Labs
- FranceDOLENIO 1178 mg, comprimé pelliculéBLUE BIO PHARMACEUTICALS (IRLANDE)
- NorwayGlucosamin OrifarmOrifarm Generics (3)
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Cyprus · Donarthril
- Czechia · Artaxin, Flexove
- Germany · Glucosamin Doppelherzpharma
- Spain · Acenam, Duartron
- France · Flexea, Osaflexan
- United Kingdom (Northern Ireland) · Glucosamine Medley Pharma, Yointy
- Greece · Donarot, Energorot
- Hungary · Cartilamin, Glukozamin Pharma Nord
- Ireland · Arthrimel, Dona
- Iceland · Glucomed
- Norway · Glucosamin Orifarm, Samin
- Poland · Flexove
- Portugal · Biartril, Glucomed
- Sweden · Artroxan, Glucomed
- Slovakia · Glucomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6bd69916-12f5-4eee-ba13-e9aca0c2e847 GET /v1/drugs/6bd69916-12f5-4eee-ba13-e9aca0c2e847?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.5",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "g",
"strength": "625 mg",
"atc_label": "glukosamiini",
"ma_number": "20514",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL23285",
"authorised_at": "2005-07-05"
}See everything about glucosamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.